Cardiac resynchronisation therapy
From guidelines to daily clinical practice: Cardiac resynchronisation therapy is increasingly important in heart failure treatment. The therapy is complex, the demands to medical technology high. Holger Zorn reports
Cardiovascular diseases
Congenital heart disease
New research carried out in the UK has revealed that young children with congenital heart disease are at risk of having harmful toxins in their blood, particularly following surgery. Mark Nicholls reports
Civilisation Diseases breaking economic growth
More than 63% of all deaths in the world are caused by so- called non-communicable diseases. In the WHO-region of Europe it’s even higher – 86%. The direct and indirect economic costs are huge – to the point of posing a real threat to growth in crisis-hit economies. Therapy alone is not enough, World Bank strategist Dr. Armin Fidler told the European Health Forum Gastein. Effective…
It's official – chocolate linked to heart health
High levels of chocolate consumption might be associated with a one third reduction in the risk of developing heart disease, finds a study published on bmj.com. The findings confirm results of existing studies that generally agree on a potential beneficial link between chocolate consumption and heart health. However, the authors stress that further studies are needed to test whether chocolate…
MitraClip Therapy Demonstrates Benefits
Results of an observational study presented at the European Society of Cardiology (ESC) meeting in Paris demonstrate that the percutaneous catheter-based MitraClip treatment improves symptoms and promotes reverse left ventricular (LV) remodeling in patients with mitral regurgitation (MR), who do not respond to cardiac resynchronization therapy (CRT).
What do patients receiving optimal medical therapy after a heart attack die from?
Because of improved management at the acute stage, the risk of dying in hospital after a heart attack has decreased by about 50% in the past 10 years. Likewise, the prescription of recommended medications when patients leave hospital, has resulted in improved survival and fewer recurrent heart attacks.
Cardiac Disease: Coronary or not?
Acute myocardial Infarction (AMI) is a major cause of death and disability. Worldwide, one in eight patients die of an ischemic heart disease. Its rapid and accurate diagnosis is critical for the initiation of effective evidence based medical management, including early revascularization, but is still an unmet clinical need. The gradual implementation of high-sensitive cardiac troponins (hs-cTnT)…
The PRODIGY study
However, the PROlonging Dual antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY (PRODIGY) also found a consistently greater risk of haemorrhage in the 24-month dual therapy group according to all prespecified bleeding definitions, including the recently proposed Bleeding Academic Research Consortium classification. The need for transfusion was also increased in the…
Solutions for Sustainable Cardiovascular Care
Siemens Healthcare presented solutions for sustainable cardiovascular care at the European Society of Cardiology (ESC) congress in Paris, France, under the motto "Are you ready for the long run?". This includes all modern imaging technologies, in-vitro diagnostics, IT solutions and consulting services.
Philips and Innovations in Heart Modeling*
Royal Philips Electronics provided clinicians from across the globe with a glimpse of future innovations designed to advance cardiac care, including the current management of cardiovascular disease (CVD) and associated cardiac conditions, during the 2011 Congress of the European Society of Cardiology (ESC).
Transcatheter aortic valve implants
Although transcatheter aortic valve implantation (TAVI) is increasingly the most used surgical procedure in Germany, only two products have been approved for routine use. Although this has prompted other medical device manufacturers to go into action, according to Professor Justus Strauch, head of cardiac surgery at the Klinikum Bergmannsheil, Bochum, no one has yet taken the lead in this…
Papworth Hospital: A constant continuing success
Recent events have again underlined the reason why Papworth Hospital in ambridgeshire, England, maintains a enowned international reputation for cardiac and thoracic procedures. As Britains largest specialist cardiothoracic hospitals, over 2,000 major heart operations were performed there in 2010. In the year ending 1 April 2011, 824 patients had coronary bypass operations, including urgent,…
Satisfaction in everyday life may protect against heart failure
While depression and anxiety have long been recognised as risk factors for heart disease, there is less certainty over the beneficial effects of a ‘positive’ psychological state. Now, according to results from a study of almost 8,000 British civil servants, published online by the European Heart Journal, researchers report that a satisfying life is indeed good for the heart.
Investigating treatment options for atrial fibrillation
The first patient has been enrolled for the largest pan-European study to determine whether an early comprehensive rhythm control strategy for the treatment of atrial fibrillation (AF) will benefit patients. Patients with recent-onset AF at risk for stroke or death are eligible for the trial. The researchers plan to enrol more than 3,000 patients from 200 centres in 11 European countries.
Building human hearts on an assembly line
An artificial heart will be implanted in a patient before the end of 2011, marking a milestone in medicine. The developers are now accelerating plans to manufacture thousands of these mechanical hearts for patients worldwide, reports John Brosky
Trends in stents and balloon angioplasty
Stent fever, first diagnosed in 1997, has been spreading throughout the medical world – fuelled by new technologies, says Holger Zorn
Cardiac Biomarkers: Pipeline or pipedream
A drop of blood can unlock secrets of the heart. By analysing the biological elements present in a blood, a physician can better understand the extent of damage or disease for patients with heart failure and more confidently prescribe a course of treatment.
A time to tackle controversies face-to-face
A hefty debate on controversial issues in cardiology is the definite intent of Congress President Professor Michel Komajda and the ESC 2011 congress organisers. To that end, he plans to open the event with a focus on disagreements among cardiologists over treatment methods. This is not the only promise of a lively meeting for congress participants, as Prof Komajda explained in conversation with…
RESPONSE trial results
Studies show that when a nurse follows patients after a cardiovascular crisis those patients stay healthier, live longer and reduce the risk of returning to hospital. Now the challenge is how to convince insurers to pay for this care, reports John Brosky.
The New York Academy of Sciences Conference
This two-day international scientific symposium follows two previously successful conferences held by the New York Academy of Sciences (NYAS), ‘la Caixa’ Welfare Projects, and the International Centre for Scientific Debate (ICSD) for researchers, physicians, scientists and representatives of the related industries, working in cardiology, vascular disease, inflammation, regenerative medicine,…
When overweight kids become heart condition adults
A modern-day childhood totally differs from what was common just a few decades ago. It is mostly spent sitting -- at school desks, in front of TV screens or before computer monitors – all combined with the sweet temptations of the kid’s food industry. According to a WHO worldwide estimate, an estimated 10% of school-age children between five and 17 years old are overweight or obese. The…
Cardiac conundrum
France – Re-opening clogged arteries with metal stents has proved a life-saver for a majority of patients with coronary disease. Yet the high rates of complications and mortality for patients with diabetes following a percutaneous coronary intervention (PCI) continue to baffle cardiologists. Report: John Brosky
Molecular Imaging Detects Ischemic Heart Disease in Diabetics
Research introduced at SNM’s 58th Annual Meeting may lead to much-needed cardiovascular disease screening for diabetic patients at risk of ischemic heart disease, a disorder marked by significantly reduced blood flow in the heart. Ischemia of the myocardium, or cardiac muscle, can signal diminished oxygenation of the heart tissue and trigger a heart attack if left untreated.
Sharper scrutiny on valve repair
One year ago interventional cardiologists raised champagne glasses to celebrate the first publication of clinical evidence showing that transcatheter valve implants (TAVI) is safe and effective. In May at EuroPCR 2011, cardiologists raised magnifying glasses to look closer at further clinical results. John Brosky reports from Paris
Celebrating a 25-year-old ‘heart’
Initially meant to bridge the gap before a heart transplant is performed, today ventricular assist devices (VADs) are increasingly considered ‘a lasting therapy option’, according to Professor Heinrich Schima, Head of the Centre for Medical Physics and Biomedical Technology at the Medical University of Vienna.
